163 related articles for article (PubMed ID: 17980170)
1. Proteolytic activation and glycosylation of N-acylethanolamine-hydrolyzing acid amidase, a lysosomal enzyme involved in the endocannabinoid metabolism.
Zhao LY; Tsuboi K; Okamoto Y; Nagahata S; Ueda N
Biochim Biophys Acta; 2007 Nov; 1771(11):1397-405. PubMed ID: 17980170
[TBL] [Abstract][Full Text] [Related]
2. Amino acid residues crucial in pH regulation and proteolytic activation of N-acylethanolamine-hydrolyzing acid amidase.
Wang J; Zhao LY; Uyama T; Tsuboi K; Tonai T; Ueda N
Biochim Biophys Acta; 2008; 1781(11-12):710-7. PubMed ID: 18793752
[TBL] [Abstract][Full Text] [Related]
3. The N-acylethanolamine-hydrolyzing acid amidase (NAAA).
Tsuboi K; Takezaki N; Ueda N
Chem Biodivers; 2007 Aug; 4(8):1914-25. PubMed ID: 17712833
[TBL] [Abstract][Full Text] [Related]
4. N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA).
Ueda N; Tsuboi K; Uyama T
Prog Lipid Res; 2010 Oct; 49(4):299-315. PubMed ID: 20152858
[TBL] [Abstract][Full Text] [Related]
5. Predominant expression of lysosomal N-acylethanolamine-hydrolyzing acid amidase in macrophages revealed by immunochemical studies.
Tsuboi K; Zhao LY; Okamoto Y; Araki N; Ueno M; Sakamoto H; Ueda N
Biochim Biophys Acta; 2007 May; 1771(5):623-32. PubMed ID: 17462942
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase.
Tsuboi K; Sun YX; Okamoto Y; Araki N; Tonai T; Ueda N
J Biol Chem; 2005 Mar; 280(12):11082-92. PubMed ID: 15655246
[TBL] [Abstract][Full Text] [Related]
7. Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages.
Sun YX; Tsuboi K; Zhao LY; Okamoto Y; Lambert DM; Ueda N
Biochim Biophys Acta; 2005 Oct; 1736(3):211-20. PubMed ID: 16154384
[TBL] [Abstract][Full Text] [Related]
8. Mass spectrometric characterization of human N-acylethanolamine-hydrolyzing acid amidase.
West JM; Zvonok N; Whitten KM; Wood JT; Makriyannis A
J Proteome Res; 2012 Feb; 11(2):972-81. PubMed ID: 22040171
[TBL] [Abstract][Full Text] [Related]
9. Expression and secretion of N-acylethanolamine-hydrolysing acid amidase in human prostate cancer cells.
Wang J; Zhao LY; Uyama T; Tsuboi K; Wu XX; Kakehi Y; Ueda N
J Biochem; 2008 Nov; 144(5):685-90. PubMed ID: 18806270
[TBL] [Abstract][Full Text] [Related]
10. Assay of NAAA Activity.
Tsuboi K; Ueda N
Methods Mol Biol; 2016; 1412():137-48. PubMed ID: 27245900
[TBL] [Abstract][Full Text] [Related]
11. N-acylethanolamine-hydrolyzing acid amidase and fatty acid amide hydrolase inhibition differentially affect N-acylethanolamine levels and macrophage activation.
Alhouayek M; Bottemanne P; Makriyannis A; Muccioli GG
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 May; 1862(5):474-484. PubMed ID: 28065729
[TBL] [Abstract][Full Text] [Related]
12. Endogenous molecules stimulating N-acylethanolamine-hydrolyzing acid amidase (NAAA).
Tai T; Tsuboi K; Uyama T; Masuda K; Cravatt BF; Houchi H; Ueda N
ACS Chem Neurosci; 2012 May; 3(5):379-85. PubMed ID: 22860206
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of potent N-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitor as anti-inflammatory compounds.
Li Y; Yang L; Chen L; Zhu C; Huang R; Zheng X; Qiu Y; Fu J
PLoS One; 2012; 7(8):e43023. PubMed ID: 22916199
[TBL] [Abstract][Full Text] [Related]
14. Molecular biology of the enzymes that degrade endocannabinoids.
Puffenbarger RA
Curr Drug Targets CNS Neurol Disord; 2005 Dec; 4(6):625-31. PubMed ID: 16375680
[TBL] [Abstract][Full Text] [Related]
15. A quantitative study on splice variants of N-acylethanolamine acid amidase in human prostate cancer cells and other cells.
Sakura Y; Tsuboi K; Uyama T; Zhang X; Taoka R; Sugimoto M; Kakehi Y; Ueda N
Biochim Biophys Acta; 2016 Dec; 1861(12 Pt A):1951-1958. PubMed ID: 27693242
[TBL] [Abstract][Full Text] [Related]
16. Endocannabinoid hydrolases.
Ueda N
Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():521-34. PubMed ID: 12432941
[TBL] [Abstract][Full Text] [Related]
17. Glycosylation and phosphorylation of lysosomal glycosylasparaginase.
Park H; Vettese-Dadey M; Aronson NN
Arch Biochem Biophys; 1996 Apr; 328(1):73-7. PubMed ID: 8638940
[TBL] [Abstract][Full Text] [Related]
18. N-Acylethanolamine-Hydrolyzing Acid Amidase Inhibition, but Not Fatty Acid Amide Hydrolase Inhibition, Prevents the Development of Experimental Autoimmune Encephalomyelitis in Mice.
Bottemanne P; Guillemot-Legris O; Paquot A; Masquelier J; Malamas M; Makriyannis A; Alhouayek M; Muccioli GG
Neurotherapeutics; 2021 Jul; 18(3):1815-1833. PubMed ID: 34235639
[TBL] [Abstract][Full Text] [Related]
19. Development of new inhibitors for N-acylethanolamine-hydrolyzing acid amidase as promising tool against bladder cancer.
Vago R; Bettiga A; Salonia A; Ciuffreda P; Ottria R
Bioorg Med Chem; 2017 Feb; 25(3):1242-1249. PubMed ID: 28062195
[TBL] [Abstract][Full Text] [Related]
20. N-acylethanolamine hydrolyzing acid amidase inhibition: tools and potential therapeutic opportunities.
Bottemanne P; Muccioli GG; Alhouayek M
Drug Discov Today; 2018 Aug; 23(8):1520-1529. PubMed ID: 29567427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
